Prognostic factors of small-cell lung cancer in Okayama Lung Cancer Study Group Trials. by Tamura, Makoto et al.
Acta Medica Okayama
Volume 52, Issue 2 1998 Article 6
APRIL 1998
Prognostic factors of small-cell lung cancer in
Okayama Lung Cancer Study Group Trials.
Makoto Tamura∗ Hiroshi Ueoka† Katsuyuki Kiura‡
Masahiro Tabata∗∗ Takuo Shibayama†† Kazuyo Miyatake‡‡
Kenichi Genba§ Shunkichi Hiraki¶ Mine harada‖
∗Okayama University,
†Okayama University,
‡Okayama Univeristy,
∗∗Okayama University,
††Okayama University,
‡‡Okayama University,
§Okayama University,
¶Okayama Cross Hospital,
‖Okayama University,
Copyright c©1999 OKAYAMA UNIVERSITY MEDICAL SCHOOL. All rights reserved.
Prognostic factors of small-cell lung cancer in
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Abstract
In order to elucidate factors influencing the prognosis of small-cell lung cancer (SCLC), we
reviewed the records of 253 patients with SCLC and evaluated 20 pretreatment prognostic factors
by univariate analysis and Cox’s multiple regression analysis. Recursive partitioning and amal-
gamation (RPA) was employed to identify subgroups with similar survival rates. Cox’s multiple
regression analysis identified five significant factors: extent of disease, number of metastatic sites,
serum albumin, serum lactate dehydrogenase, and presence of weight loss. Among these, ex-
tent of disease was the most influential factor. RPA analysis revealed three subgroups predicting
significantly different prognoses. The median survival time and 3-year survival rate were 18.4
months and 20.6%, respectively for the good-risk group (limited disease without weight loss),
13.5 months and 9.1%, respectively for the intermediate-risk group (limited disease with weight
loss or extensive disease with less than two metastatic sites), and 9.2 months and 0%, respectively
for the poor-risk group (extensive disease with two or more metastatic sites). These results will be
useful for development of new staging system or subsequent stratification for randomized trials.
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